Author:
Boissinot M,Cleyrat C,Vilaine M,Jacques Y,Corre I,Hermouet S
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference55 articles.
1. Aman MJ, Bug G, Aulitzky WE, Huber C, Peschel C . (1996). Inhibition of interleukin-11 by interferon-alpha in human bone marrow stromal cells. Exp Hematol 24: 863–867.
2. Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, Cancer Genome Project et al. (2005). Acquired mutation of the tyrosine kinase JAK-2 in human myeloproliferative disorders. Lancet 365: 1054–1061.
3. Bernet A, Mehlen P . (2007). Dependence receptors: when apoptosis controls tumor progression. Bull Cancer 94: E12–E17.
4. Cleyrat C, Jelinek J, Girodon F, Boissinot M, Ponge T, Harousseau J-L et al. (2010). JAK2 mutation and disease phenotype: A double L611V/V617F in cis mutation of JAK2 is associated with isolated erythrocytosis and increased activation of AKT and ERK1/2 rather than STAT5. Leukemia 24: 1069–1073.
5. Comoglio PM, Giordano S, Trusolino L . (2008). Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat Rev Drug Discov 7: 504–516.
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献